
Recent Articles
Amarin Stock Will Deliver More Upside for Patient Investors
By
Todd Shriber, InvestorPlace Contributor
As Vascepa's competition dwindles and the drug gains market share, AMRN stock could be in for some significant upside in 2020.
Get in on NVDA Stock While the Getting Is Still Good
By
Todd Shriber, InvestorPlace Contributor
With semiconductor stocks extending 2019's surge and growth and momentum stocks, of which Nvidia is one, continuing to top value, it seems like the path of least resistance is to be bullish on Nvidia. That doesn't mean the sailing is always going to be smooth. In fact, not all of the analysts covering the chip maker are enthusiastic about the stock.
Scorching Hot Nio Stock May Have Some More Upside Left Atop EV Equities
By
Todd Shriber, InvestorPlace Contributor
Nio stock jumped almost 7% with double volume on news of a billion-dollar injection. Investors should realize that headlines can cut both ways.
Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks
By
Todd Shriber, InvestorPlace Contributor
There are now roughly 3,000 confirmed cases of the coronavirus around the world with 80 deaths. In both instances, the bulk of the problem is sourced to the central Chinese province of Hubei, mainly the capital city of Wuhan. Hence the term “Wuhan virus.”
3 Safe ETFs to Buy for an Overvalued Market
By
Todd Shriber, InvestorPlace Contributor
Gaining value and safety in the same investment vehicle can be a daunting task, but these three safe ETFs show it's possible and profitable.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.